Suppr超能文献

原发性黏液样/圆细胞脂肪肉瘤的预后因素及转移模式

Prognostic factors and metastatic patterns in primary myxoid/round-cell liposarcoma.

作者信息

Haniball J, Sumathi V P, Kindblom L-G, Abudu A, Carter S R, Tillman R M, Jeys L, Spooner D, Peake D, Grimer R J

机构信息

The Royal Orthopaedic Hospital Oncology Service, Royal Orthopaedic Hospital NHS Foundation Trust, Bristol Road South, Birmingham B31 2AP, UK.

出版信息

Sarcoma. 2011;2011:538085. doi: 10.1155/2011/538085. Epub 2011 Nov 28.

Abstract

Background. This study aimed to investigate prognostic factors for patients with myxoid/round-cell liposarcoma (MRCLS), in particular the significance of the round cell component, and to identify metastatic patterns as well as possibly suggest a suitable strategy for followup. Methods. Clinical, morphologic, and follow-up data from 160 patients with MRCLS was reviewed and statistically analysed. Results. Of 130 tumours with the round cell component evaluated, 61 had no round cell component, 27 had <5% round cell component, and 42 had >5%. All patients underwent surgical excision, 15 requiring amputation. 107 patients received adjuvant radiotherapy. Local recurrence occurred in 19 patients (12%), predominantly in patients with marginal or intralesional margins and a round cell component. Overall disease specific survival was 75% at 5 years and 56% at 10 years and was related to the proportion of round cell component. Of 52 patients who developed metastases, 38 (73%) had purely extrapulmonary metastases. We could not identify any factors predicting the site of metastases developing. Conclusions. The occurrence of any round cell component is the most important adverse prognostic factor for patients with MRCLS; patients with >5% round cell component are at higher risk of local recurrence, metastasis and tumour-related death and should be considered for adjuvant radiotherapy and possibly chemotherapy. The best method of monitoring extrapulmonary metastases remains to be established.

摘要

背景。本研究旨在调查黏液样/圆形细胞脂肪肉瘤(MRCLS)患者的预后因素,特别是圆形细胞成分的意义,确定转移模式,并可能提出合适的随访策略。方法。回顾并统计分析了160例MRCLS患者的临床、形态学和随访数据。结果。在评估的130例有圆形细胞成分的肿瘤中,61例无圆形细胞成分,27例圆形细胞成分<5%,42例圆形细胞成分>5%。所有患者均接受了手术切除,15例需要截肢。107例患者接受了辅助放疗。19例患者(12%)发生局部复发,主要发生在手术切缘为边缘性或瘤内性且有圆形细胞成分的患者中。5年时总体疾病特异性生存率为75%,10年时为56%,且与圆形细胞成分的比例有关。在发生转移的52例患者中,38例(73%)仅有肺外转移。我们未能确定任何预测转移发生部位的因素。结论。任何圆形细胞成分的出现是MRCLS患者最重要的不良预后因素;圆形细胞成分>5%的患者局部复发、转移和肿瘤相关死亡的风险更高,应考虑接受辅助放疗,可能还需化疗。监测肺外转移的最佳方法仍有待确定。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/142a/3236386/d9cc9ae93abe/SRCM2011-538085.001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验